Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2009

Feb 25, 2009

29777_dirs_2009-02-25_f5c42fd2-647c-4806-bbd9-f1e7550f6509.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADVANCED MEDICAL OPTICS INC (EYE)
CIK: 0001168335
Period of Report: 2009-02-25

Reporting Person: ABBOTT LABORATORIES (10% Owner)
Reporting Person: Rainforest Acquisition Inc. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-25 Common Stock P 56395914 $22.00 Acquired 58846214 Indirect

Footnotes

F1: This form is a joint filing by Abbott Laboratories ("Abbott") and Rainforest Acquisition Inc., a wholly-owned subsidiary of Abbott (the "Purchaser"). This Form 4 relates to shares of common stock, par value $0.01 per share (the "AMO Common Stock"), and the associated preferred stock purchase rights issued in connection with the Rights Agreement, dated June 24, 2002, by and between Advanced Medical Optics, Inc., a Delaware corporation ("AMO"), and Mellon Investor Services, LLC (together with the AMO Common Stock, the "AMO Shares"), of AMO.

F2: The AMO Shares that are the subject of this report were acquired by the Purchaser upon the expiration of the Purchaser's offer to purchase all of the outstanding AMO Shares as disclosed in the Tender Offer Statement on Schedule TO, as amended or supplemented, initially filed with the Securities and Exchange Commission on January 27, 2009 by Abbott and the Purchaser.

F3: Includes 6,657,258 AMO Shares tendered through guaranteed delivery procedures.